mn(iii) 5,10,15,20-tetrakis(n-methylpyridinium-2-yl)porphyrin has been researched along with hydroxyl radical in 1 studies
| Studies (mn(iii) 5,10,15,20-tetrakis(n-methylpyridinium-2-yl)porphyrin) | Trials (mn(iii) 5,10,15,20-tetrakis(n-methylpyridinium-2-yl)porphyrin) | Recent Studies (post-2010) (mn(iii) 5,10,15,20-tetrakis(n-methylpyridinium-2-yl)porphyrin) | Studies (hydroxyl radical) | Trials (hydroxyl radical) | Recent Studies (post-2010) (hydroxyl radical) |
|---|---|---|---|---|---|
| 69 | 0 | 42 | 10,147 | 26 | 3,657 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Knox, SJ; Peehl, DM; Tian, J | 1 |
1 other study(ies) available for mn(iii) 5,10,15,20-tetrakis(n-methylpyridinium-2-yl)porphyrin and hydroxyl radical
| Article | Year |
|---|---|
Metalloporphyrin synergizes with ascorbic acid to inhibit cancer cell growth through fenton chemistry.
Topics: Antioxidants; Apoptosis; Ascorbic Acid; Blotting, Western; Catalase; Cell Proliferation; Drug Synergism; Glutathione; Glutathione Reductase; Humans; Hydrogen Peroxide; Hydroxyl Radical; Liver Neoplasms; Male; Manganese; Membrane Potential, Mitochondrial; Metalloporphyrins; Neoplasms, Hormone-Dependent; Oxidation-Reduction; Pancreatic Neoplasms; Prostatic Neoplasms; Reactive Oxygen Species; Superoxides; Tumor Cells, Cultured | 2010 |